TipRanks
Go Ultimate55% OFF

Peter N. Kellogg Insider Profile

4 Followers

Peter N. Kellogg, Director at Alnylam Pharma, holds 1.45K shares in Alnylam Pharma (Ticker: ALNY), holds 12.50K shares in Yield10 Bioscience (Ticker: YTENQ), holds 49.69K shares in Celgene (Ticker: CELG).

Peter N. Kellogg's Trading History

ALNY
Alnylam Pharma
May 22, 2026DirectorUninformative Buy―$238.59K
YTENQ
Yield10 Bioscience
Jul 05, 2017DirectorUninformative Buy――
CELG
Celgene
Feb 16, 2017―Uninformative Buy―$5.38M
MRK
Merck & Company
Feb 26, 2014Exe V-P & CFOUninformative Buy1.05M$22.36M
BIIB
Biogen
―EVP, Finance and CFO―$4.81M

You May Also Like

Peter N. Kellogg insider profile FAQ

What stocks does Peter N. Kellogg hold?
Peter N. Kellogg holds: ALNY, CELG, YTENQ, MRK, BIIB stocks.
What was Peter N. Kellogg's most profitable transaction?
Peter N. Kellogg’s most profitable transaction was an Informative Buy of MRK stock on August 15, 2011. The return on the trade was 43.50%.
What is Peter N. Kellogg's role in Alnylam Pharma?
Peter N. Kellogg's role in Alnylam Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.